Mr. Chairman, members of the Subcommittee, thank you for the
opportunity to speak before
you today and for your leadership in the battle against breast
cancer. I am Dr. Susan Blumenthal,
Deputy Assistant Secretary for Women's Health and Assistant
Surgeon General in the U.S.
Department of Health and Human Services. I direct the U.S.
Public Health Service's Office on
Women's Health, the focal point for women's health issues in the
Department that coordinates
women's health research, health care services, policy and public
and health care professional
education across the Department, collaborating with other
government organizations, and
consumer and health care professional groups to advance women's
health in the United States and
internationally.
My remarks will address current Departmental programs to improve
breast cancer detection and
diagnosis to ensure that today's mammography is of the highest
quality and that women have
increased access to this lifesaving technology. I then will
describe other initiatives underway,
some in partnership with other Federal agencies, to bring the
field of breast imaging into the 21st
century-- to develop more accurate methods to detect and diagnose
this disease in all women. I
also will provide you with a progress report on Departmental
efforts in the fight against breast
cancer.
As you know, breast cancer is one of the most complex and
devastating public health problems in
our country today. It is perhaps the most dreaded and feared
disease in women. It has become an
epidemic in our country: the number of women affected by this
disease has increased from I in 20
over a lifetime in the 1950s to 1 in 8 today. And, while there
has been good news in that the
overall mortality rate from breast cancer has dropped for the
first time in recent history-5% among
women nationwide-the death rate continues to increase for women
of color, though at a far slower
rate than ever before. It is thought that this overall positive
trend is related to the increased use of
screening mammography by women in this decade, coupled with
improvements in treatment.
IMPROVING CONVENTIONAL MAMMOGRAPHY
Since currently there is no cure for breast cancer or method to
prevent it from occurring, the key to
saving women's lives is the early detection of the disease, when
treatment is the most effective and
survival rates are best. That is where today's x-ray mammography
has proven crucial.
Mammography is a life-saving technology that can detect breast
cancer more than 1-2 years before
a lump can be felt. Experts agree that it can decrease mortality
rates by 30% in women over the
age of 50. And, when it is detected at its earliest stages, 5
year survival rates are 93 % and 10 year
survival is 76%. Early detection also means that breast sparing
surgery-lumpectomy--can be
performed.
FDA Implementation of the Mammography Quality Standards Act
Until just two years ago, a woman could go to a mammography
facility and not know if the
machine was 20 years old or whether the person who positioned her
for the test or interpreted the
x-ray had adequate training. The Food and Drug Administration's
implementation of the
Mammography Quality Standards Act now ensures that women are
guided to the safest and most
reliable mammography in their communities. Today, it is illegal
for mammography facilities to
operate without certification by the FDA.
Mammography Guidelines
Recognizing the importance of the quality of screening mammograms
in the early detection of
breast cancer, the Agency for Health Care Policy and Research
(AHCPR) developed Clinical
Practice Guidelines --Quality Determinants of mammography-- with
separate versions for
mammography providers, health care professionals, and consumers.
The guidelines define the
areas of responsibility for each member of the health care team
delivering mammograms,
including women themselves.
CDC Breast and Cervical Cancer Early Detection Program
Additionally, the Centers for Disease Control and Prevention's
Breast and Cervical Cancer Early
Detection Program is providing mammograms nationwide at low or no
cost to women who cannot
afford them. To date, over I million low-income, minority and
underserved women have been
screened for breast or cervical cancer under this important
nationwide initiative that includes all 50
states, 3 territories, the District of Columbia and 13 American
Indian tribes.
Medicare Initiative
Breast cancer is primarily a disease of older women, with 60% of
cases occurring in women over
the age of 65. However, nearly 2/3 of older women don't use
Medicare's mammography screening
benefit. In direct response, two years ago, the Administration
launched an educational campaign
to encourage the use of mammography by Medicare-eligible older
women.
Public Education
There are many barriers that keep women from using mammography,
such as cost, fear, concern
about pain and radiation exposure, and inadequate information
about the value of early detection.
In an effort to help break down these barriers, the U.S.
Department of Health and Human Services
has undertaken educational initiatives, often in partnership with
public and private sector
organizations, to increase women's use of screening mammography.
The National Cancer Institute (NCI), for example, supports three
important leadership initiatives-the National Black Leadership
Initiative on Cancer, the National Hispanic Leadership Initiative
on
Cancer, and the Appalachian Leadership Initiative on Cancer. The
first two initiatives address a
broad range of cancer control issues. The last program focuses
specifically on improving breast
and cervical cancer outreach activities.
Moreover, the Centers for Disease Control and Prevention (CDC)
has developed educational
collaborations at the national level with a broad range of
private sector, public sector, and
consumer groups, supporting programs of national
organizations-from the AARP to the YWCA of
the USA, and from the American Indian Healthcare Association to
the National Migrant Resource
Program-to educate their constituencies about breast and cervical
cancer, to increase access to
screening programs, and to develop methods to reach underserved
and other priority populations.
Further, the Department has made the latest information about
breast cancer available to the public
and to health care providers free through Federal resources, such
as the NCI's information line, 1-800-4-CANCER, by the cancer-fax,
and on the Internet. And in November 1996, the Office on
Women's Health launched an Internet web-site for the National
Action Plan on Breast Cancer
(NAPBC) that provides answers to frequently asked questions about
breast cancer and serves as a
gateway to information on research, organizations, advocacy
groups, educational conferences and
meetings, publications and other resources about breast cancer.
The web-site is found at:
www.napbc.org.
New Frontiers in Breast Imaging
Despite these improvements and initiatives to improve the quality
and utilization of
mammography, it is nonetheless a 40-year-old technology. It
misses 15% to 20% of cancers, and
80 percent of lesions found by the technology are benign,
resulting in unnecessary medical
procedures, including surgical biopsies. This is why the
Department has made it a priority to bring
a new generation of breast cancer detection technologies to the
battle against this disease. A range
of studies are now being supported-from basic instrumentation and
technology development to
preclinical and clinical evaluation that have the potential for
revolutionizing breast cancer
detection and diagnosis. Let me describe some of these new
technologies to you.
Ultrasound
Breast ultrasound, unlike other innovative imaging techniques
that I will discuss, already has an
established role in the diagnosis and management of breast
disease. High-resolution breast
ultrasound can determine whether lesions found on clinical
examination are benign cysts or solid
lesions. The features of solid masses can be further analyzed
with high-resolution ultrasound to
help differentiate those that are most likely to be benign from
those with malignant characteristics.
The same technology can be used to guide procedures such as
aspiration of cysts and needle
biopsies of suspicious solid masses.
Digital Mammography
Digital mammography is among the most promising new technologies
for improved detection of
breast cancer for large scale grams. In sharp contrast to
conventional
mammography, digital mammography generates images directly on a
computer where the image
can be digitally enhanced, improving image quality and allowing
radiologists to detect smaller
lesions using lower radiation doses. In addition, digital
mammography opens up new avenues for
improved detection, including computer assisted diagnosis, where
the computer serves as a second
opinion," enhancing radiologic interpretation and improving the
ability to distinguish benign from
cancerous lesions and telemammography where, using telemedicine,
breast images can be transmitted by
computer and satellite from community clinics and remote areas to
academic centers or other sites for
expert radiologic consultation. As we enter the 21st century,
telemammography will bring state-of-the-art
academic radiologic expertise to underserved populations in our
nation and internationally.
Today, an international multi-disciplinary collaboration of
academic centers, and industry,
supported by the NCI, is facilitating the development, validation
and implementation of digital
mammography.
Breast MRI
Magnetic resonance imaging (MRI) involves the creation of images
from signals generated by the
excitation of nuclear particles in a magnetic field. Breast MRI
has emerged as one of the most
promising novel technologies for the detection and staging of
breast cancer in women, particularly
for those with radiodense breast tissue for whom traditional or
digital x-ray mammography may
not be as effective. Unlike either conventional or digital
mammography, MRI does not involve
ionizing radiation.
Research suggests that MRI is able to pinpoint suspicious lesions
camouflaged behind dense breast
tissue that traditional x-ray based mammograms have been unable
to penetrate sufficiently to
accurately detect. Additionally, MRI appears to be unique in its
ability to define the size, shape
and potential spread in the breast of the tumor, critical for
disease staging and treatment planning.
Preliminary data suggest that this technology can detect lesions
as small as 1-3 mm and that high
resolution MRI can improve the differentiation of benign lumps
from cancerous ones.
Positron Emission Tomography (PET)
The ultimate goal of new breast imaging technologies is to detect
breast cancer at its earliest
stages-ideally when only a few cells are present, and long before
conventional mammography can
detect a tumor. That's where the field of molecular imaging
comes in. Positron Emission
Tomography-the PET scan-is a nuclear medicine imaging technology
that produces an image of
the biochemical and physiological processes in the body. PET
makes it possible to detect primary
tumors as well as the spread of breast cancer to the lymph nodes
and other regions of the body. It
is also able to image estrogen receptors and chemotherapeutic
agents.
IMPORTANCE OF FEDERAL AGENCY COLLABORATIONS
The Missiles to Mammograms Project
Deeply concerned about the limitations in conventional
mammography, the U.S. Public Health
Service's Office on Women's Health 2 « years ago developed the
"New Frontiers in Breast Imaging:
From Missiles to Mammograms" initiative to adapt advanced
defense, space, and intelligence imaging
technologies from the DOD, CIA and NASA -- capabilities estimated
to be about I 0 years ahead of
medical imaging -- to the early and more accurate detection of
breast cancer.
Medical and intelligence imaging share some common challenges.
Both must scan and compare
two or more large areas to detect and precisely locate small
subtle changes in topography-the tank
that has been deployed onto a landscape and is camouflaged behind
trees; the small cancerous
tumor growing deep in a woman's breast, camouflaged by dense
breast tissue. And, in both
intelligence and medical applications, an incorrect analysis-a
missed cancer or a missed military
target-can have tragic consequences.
Using CIA-developed computer algorithms called neural networks
(modeled after human brain
cells), a computer "learns" the features of the terrain from
surveillance photographs and can detect
subtle changes in visually matched photographs taken over time,
identifying the construction of
new buildings or troop movements, for example, and distinguishing
them from the context or
"normal" landscape. Applying this CIA technology to the
detection of breast cancer, a computer
can be "trained" to recognize the features of an individual
woman's breast-including the regions of
cancer deposits, such as microcalcifications, that might not be
found on digital mammography. In
this way, the computer acts as a "second reader." Preliminary
results have found that the CIA's
neural network technology improves the accuracy of mammography.
This new technology is now
being tested in a major multi-site clinical trial conducted by
the University of Pennsylvania in
collaboration with several other academic and industrial
partners, supported by the U.S. Public
Health Service's Office on Women's Health.
Another component of this multi-site clinical trial is the
application of CIA technology used to
simulate 3-dimensional missile launches to improve MRI's
diagnostic capabilities, creating 3 -dimensional pictures of the
breast where the volume, shape and size of a tumor can be
visualized.
This technology is providing a new method to determine the extent
and spread of cancerous
growth, to improve the accuracy of biopsies, and to monitor tumor
response to treatment.
Breast Biopsies
Imaging technology is also being used in performing biopsies.
Eighty percent of women in the
United States who undergo surgical breast biopsies do not have
cancer. As an alternative to
surgical tissue removal, image-guided needle breast biopsy that
uses the optics from the Hubble
telescope developed by NASA is being studied for women with
non-palpable lesions. Image-
guided needle biopsy offers the potential advantages of minimized
tissue damage, reduced waiting
time until diagnosis, and cost savings. A multi-institutional
research program is now testing the
efficacy and cost-effectiveness of large-core and fine-needle
biopsies compared with more
extensive surgical biopsies.
Other research is developing methods to detect products of breast
cancer (antigens) in blood, urine,
or nipple aspirates, and to detect genetic alterations in women
who are at increased risk for breast
cancer. Once cancer is diagnosed, studies of these types
contribute to characterization of breast
tumors and can be useful in treatment planning.
Facilitating New Technology Transfer Opportunities
To bring these and other promising new cutting-edge technologies
to reality in the diagnosis and
treatment of breast cancer, the U.S. Public Health Service's
Office on Women's Health established
the Federal Multi-Agency Consortium on Imaging Technologies to
Improve Women's Health,
with diverse membership across Federal agencies, (including the
Department of Health and
Human Services, FDA, Department of Defense, Central Intelligence
Agency, Department of
Energy and the Department of Commerce) to foster the
identification, evaluation, and transfer of
intelligence, space, energy, defense, and other relevant
technologies to advance the current state-of-the-art in the early
detection and diagnosis of diseases in women, including breast
cancer.
DHHS Breast Cancer Initiatives
These new initiatives to improve breast cancer detection and
diagnosis are a critical component of
the Department of Health and Human Service's all-out assault
against breast cancer. Today, real
financial muscle has been put behind the Administration's
commitment to eradicating this major
killer of American women.
HHS Spending on Breast Cancer
HHS funding for breast cancer research, prevention and treatment
has increased from
approximately $276 million in FY 1993 to an estimated $541
million in FY 1997. The Centers for
Disease Control and Prevention (CDC) are working to increase
access for all women to
mammography screening and follow-up services, with resources
devoted to breast cancer services
having increased from $42 million in FY 1993, to $81 million in
FY 1997. Cancer research is
vital to our understanding of how to prevent, detect and treat
breast cancer. The Clinton
Administration has intensified research efforts on breast cancer
at the National Institutes of Health
by increasing funding from $229 million in FY 1993, to $430
million in FY 1997. FDA will
spend about $26 million in FY 1997 to implement the Mammography
Quality Standards Act.
HHS also helps provide treatment for breast cancer patients
through the Medicare I -- #-and
Medicaid programs and through the Indian Health Service.
Federal Breast Cancer Coordinating Committee
Additionally, for the first time, all agencies of government have
been mobilized to join in the
battle against this disease through the establishment and work of
a Federal Interagency
Coordinating Committee on Breast Cancer that is fostering new
collaborations in the fight against
this illness. A Federal inventory of breast cancer-related
initiatives has been prepared that will
soon be available on the world-wide web homesite of the National
Action Plan on Breast Cancer.
National Action Plan on Breast Cancer
In October 1993, the National Breast Cancer Coalition presented
President Clinton a petition with
2.6 million signatures urging that there be a new national
strategy to fight this disease. DHHS
Secretary Donna Shalala convened a conference two months later,
in December 1993, followed by
the establishment of the National Action Plan on Breast Cancer,
an innovative public-private
partnership that is catalyzing new action in research, health
care service delivery, and education
about the disease. The implementation of the Plan is coordinated
by the Office on Women's
Health.
The Plan involves public/private working groups on a number of
high priority action areas,
including: (1) increasing research on the causes of breast
cancer, particularly the role played by
environmental factors; (2) increasing participation of women in
clinical trials; (3) developing
national biological resource banks; (4) establishing a
comprehensive plan for counseling and
educating women about the newly-identified breast cancer genes;
(5) using new information
technologies to improve breast cancer education for consumers and
health care providers; and (6)
involving consumers in policy and research decisions. Many new
cross-cutting initiatives have
been implemented in each of these areas.
Breast Cancer Among the Elderly
The Agency for Health Care Policy and Research (AHCPR) is
currently funding a five-year
Patient Outcomes Research Team study on the care, costs, and
outcomes of early stage breast
cancer. The study will examine three alternative treatments for
early stage breast cancer in the
elderly: modified radical mastectomy, breast-conserving surgery
with radiotherapy, and breast-
conserving surgery without radiotherapy. The project will look
at quality and cost-effectiveness in
these projects and will develop clear recommendations for
treating early stage breast cancer in the
elderly.
Office of Cancer Survivorship
Progress is being made in the battle against cancer. Today, we
have an entire generation of
Americans who can call themselves cancer survivors. On October
27, 1996, President Clinton
unveiled the new Office of Cancer Survivorship at the National
Cancer Institute. Recent success
of cancer prevention, early detection, and treatment efforts has
created a new need: research into
the physical, psychological, and economic well-being of the
growing number of cancer survivors.
The Office of Cancer Survivorship will support studies covering
the range of issues facing
survivors of cancer, including: long term medical and
psychological effects; factors that
predispose survivors to second malignancies; reproductive
problems following cancer treatment;
and their unique insurance and employment issues.
Closing
These initiatives and programs reflect the progress that is being
made in the fight against breast
cancer. Both the Administration and the Congress have made it a
top national health priority. The
Department's efforts to eradicate this disease are deployed on
many fronts: increasing basic and
clinical research, improving early detection and diagnosis, and
enhancing the range and
effectiveness of treatments and preventive interventions and
improving access to breast cancer
services.. We are grateful for the Committee's support and pledge
to continue our work together
until this war is won. I would be pleased to answer any
questions you may have.